Clinical Trials Logo

Glucose Tolerance clinical trials

View clinical trials related to Glucose Tolerance.

Filter by:

NCT ID: NCT06193291 Completed - Glucose Tolerance Clinical Trials

Effect of Hot Water Immersion on Heart Rate Variability and Glucose

HWI
Start date: March 2, 2020
Phase: N/A
Study type: Interventional

Heat therapy has been shown to reduce risk of various diseases, including heart disease, alzheimers, and pneumonia, as well as all-cause mortality . A previous study found heating a single hand lowers postprandial blood glucose levels with a magnitude similar to certain exercise interventions such as 40 minutes of slow walking We propose that heating both feet and heating both legs up to the calves will result in similar glucose reductions in a dose response manner.Overview To determine the effect of heating both feet to the ankles and heating both legs to the calves on postprandial blood glucose

NCT ID: NCT05300256 Recruiting - Glucose Tolerance Clinical Trials

Peripheral Heating and Glucose Tolerance

Start date: March 18, 2022
Phase: N/A
Study type: Interventional

Effect of peripheral heating on glucose tolerance

NCT ID: NCT04966299 Recruiting - Insulin Resistance Clinical Trials

Effect of Daily Erythritol Versus Sucrose Intake Over 5 Weeks on Glucose Tolerance in Adolescents

EryAdo
Start date: August 18, 2021
Phase: N/A
Study type: Interventional

Childhood and adolescence are crucial periods for prevention of obesity, as obese children are five times more likely to be obese at adulthood than lean children. To this purpose, sugar consumption should be reduced. The sugar alcohol erythritol is increasingly popular as sugar substitute in the food industry and is also recommended to diabetic patients. The substance is freely available. Recent acute studies show that erythritol has a positive influence on satiation and gastric emptying without affecting insulin and plasma glucose. In this trial, the investigators aim to assess the effect of a chronic intake of erythritol versus sucrose on insulin resistance in healthy adolescents. EryClot-Pilot: Erythritol is also produced by the human body and possibly elevated erythritol levels in the blood are an indication of an increased risk of cardiovascular disease, obesity or diabetes in the future. In a recently published study, a possible effect of erythritol on blood clotting function was described. In this in vitro experiment, increased blood clotting was observed when erythritol was added to clotting cells (platelets) in the test tube. Studies in humans on blood coagulation after administration of erythritol are missing so far. With a pilot study, the investigators study whether erythritol is detectable in the blood after administration of glucose and fructose. Furthermore, the erythritol level in the blood and a possible effect on the blood coagulation function after administration of erythritol will be investigated. These preliminary tests serve to clarify the data situation so that further studies can be based on them.

NCT ID: NCT04904133 Completed - Healthy Population Clinical Trials

Effects of Low/No Calorie Sweeteners on Glucose Tolerance

Start date: April 2, 2019
Phase: N/A
Study type: Interventional

This study aims to determine the effects of chronic exposure to some low/no calorie sweeteners (LNCS) on glucose tolerance and glucagon like peptide 1 (GLP-1) release in healthy individuals. LNCS examined in this study are saccharin, sucralose and aspartame+acesulfame-K. The amounts of LNCS given to the participants are kept similar to daily life exposure; far less than the Acceptable Daily Intakes (ADIs) levels proposed by Food and Drug Administration (FDA) or European Food Safety Authority (EFSA).

NCT ID: NCT04439630 Completed - Glucose Tolerance Clinical Trials

Effects of Nopal Fractions on Postprandial Glucose Regulation and Appetite Variables in Healthy Humans

Start date: July 1, 2020
Phase: N/A
Study type: Interventional

Postprandial effects of Nopal fractions on glucose and appetite regulation will be investigated in healthy humans, in a randomised controlled crossover trial

NCT ID: NCT03872557 Completed - Glucose Tolerance Clinical Trials

Modulating Glucose Tolerance With Dietary Tyrosine

Start date: August 7, 2019
Phase: N/A
Study type: Interventional

Metabolic or Bariatric surgery is an effective treatment for type 2 diabetes mellitus (T2DM) diabetes associated with obesity. There remain some questions about the biochemical mechanism that drive how these surgeries work to reverse hyperglycemia. In the proposed human studies, the investigators will test the hypothesis that the amino acid tyrosine is a key metabolite in regulating blood sugar levels and that manipulation of the amount tyrosine supplied by nutrition is able to achieve some of the metabolic benefits seen in the early post-surgical period following bariatric surgery. The central hypothesis is that that the tyrosine content of the meal challenge affects post-prandial intestinal and plasma dopamine and levodopa and L-3,4-dihydroxyphenylalanine (L-DOPA) levels, which, in turn, impact β-cell insulin secretion and glucose excursions. The investigators now propose to characterize the possible effects of manipulating dopamine and L-DOPA levels in the gut and plasma on glucose tolerance, insulin secretion, and insulin sensitivity in healthy volunteers with a range of body mass indexes (BMIs).

NCT ID: NCT03725969 Recruiting - Insulin Sensitivity Clinical Trials

Effect of Camel Milk on Insulin and Incretin Response

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

To examine the differential effect of camel and cow milk on the physiological response, to a liquid mixed-meal challenge, in people with normal glucose tolerance

NCT ID: NCT03714438 Completed - Glucose Tolerance Clinical Trials

Effect of Medicago Sativa on Oral Glucose Tolerance in Healthy Adults

Start date: February 7, 2017
Phase: Phase 2
Study type: Interventional

Previous preclinical investigations have found that Medicago sativa promotes the decrease of glucose concentrations. To evaluate the acute effect of Medicago sativa administration on glucose tolerance, insulin secretion, and insulin sensitivity in healthy individuals.

NCT ID: NCT03423381 Completed - Glucose Tolerance Clinical Trials

Dietary Fibre and Metabolic Benefits

Start date: May 30, 2018
Phase: N/A
Study type: Interventional

The aim of the project is to study the connection between bacterial fermentation in the colon of prebiotic substrates and effects on systemic metabolism and appetite i healthy humans

NCT ID: NCT02913079 Completed - Physical Activity Clinical Trials

The Acute Impact of Sit-stand Desks on Post-meal Blood Sugar Levels

Start date: September 2016
Phase: N/A
Study type: Interventional

Context and Rationale: Uninterrupted sitting is associated with increased risk of diabetes, heart disease, and death, even among people who are physically active. These relationships are likely due to increases in post-meal blood sugar observed when people sit for long periods (e.g. > 1 hour) without interruption. In contrast to sitting, standing results in large reductions in post-meal blood sugar levels. Our group has recently shown that sit-stand desks result in large (e.g. 2.5 hour/day) reductions in occupational sitting time. Taken together, these findings suggest that sit-stand desks may help to reduce post-meal blood sugar levels. However, this has yet to be examined in the field. Theoretical Approach and Objectives: The objective of this randomized crossover study is to determine whether people have lower blood sugar when using a sit-stand desk, in comparison to a desk that can only be used while sitting. Methods and Procedures: Sixteen participants will be asked to wear a continuous glucose monitor to measure their blood sugar levels during 2 separate conditions. During one condition, they will be asked to use a sit-stand desk to sit and/or stand as much as they like during 1 workday. During the other condition, they will be asked to work at a seated desk for 1 workday. Participants will be provided with identical meals to eat during each of the two conditions. We hypothesize that participants will have lower blood sugar levels on the day when they use the sit-stand desk, in comparison to the day using a traditional seated desk. Significance and Future Use: If our results support this hypothesis, this would suggest that sit-stand desks may be a useful way to reduce blood sugar levels in people at risk for diabetes. This could also lead to larger population-based interventions studying the health impact of sit-stand desks.